Enter an event title or description
Select an event type
Select a region
Select a topics

CONGRESS 2023 - The tyranny of learning outcomes

The tyranny of learning outcomes

CONGRESS 2023 - Training of individuals undertaking dissection qualification

Training for Biomedical Scientists is a fast-growing field and has become a crucial factor in the efficiency of histopathology departments. It has many benefits from improving turnaround times, career progression and utilising Pathologist’s time more effectively. As more Biomedical Scientists are performing dissection the responsibility to teach, and train is down to the already practicing BMS dissectors rather than the Pathologists. It is imperative that training is performed correctly and suitably for the individuals, the patients, and the department as a whole. Many aspects need to be considered to deliver effective training and being fully prepared and organised for training can make the process a successful one.

CONGRESS 2023 - Transformation in Cellular Pathology

This presentation will focus primarily on one discipline, cellular pathology, complimentary transformational projects of work will be explored including digital pathology and advancement of the biomedical scientist workforce.

CONGRESS 2023 - Transforming diagnostic services - from policy to implementation

Transforming diagnostic services - from policy to implementation

CONGRESS 2023 - Troubleshooting specialist demonstration techniques

This interactive presentation will discuss general demonstration techniques, troubleshooting, and how to make the best out of the feedback you receive from your UK NEQAS CPT Results reports. The content will also cover – how to manage SOPs, importance of understanding mechanisms of action and uses of stains, recording, monitoring, and trending of IQC failures and use of UK NEQAS CPT resources to help improve staining.

There will also be an opportunity for delegates to join in and score examples of stained slides against the UK NEQAS CPT assessment criteria.


This presentation will focus on the PD-L1 clones used for the different indications, acceptable and not acceptable tests, and the importance of ideal controls.

Delegates attending this presentation will:

Receive an overview of PD-L1 EQA assessments carried out by UK NEQAS ICC & ISH
Gain a better understanding of the UK NEQAS PD-L1 schemes and how assessments are carried out.

CONGRESS 2023 - Understanding and evidencing the new HCPC Standards of Practice

Understanding and evidencing the new HCPC Standards of Practice

CONGRESS 2023 - Use of apprenticeships at different levels as a route into the Biomedical Science profession

This talk will look at apprenticeships in Healthcare Science and specifically Life sciences. Key information around what an apprenticeship is, the different levels there are, what an apprentice can do in the lab and progression to support workforce issues and development. Sharing of apprenticeship experience, ways to progress and apprentice voice.

CONGRESS 2023 - Using digital technology to revolutionise how we learn

Digital technology has opened new doors to knowledge and made education more accessible, helping to break down barriers that once limited learning opportunities. Education 2.0; Education 3.0 and most recently Education 4.0 have shown how technology can accelerate teaching, learning and assessment in fundamental ways; education has become a networkable commodity that is no longer reliant on the didactic model of student and teacher. Myriad e-learning platforms, virtual classrooms and online resources now provide easier access than ever before to quality educational materials, helping to level the playing field for academic growth.

Despite the tremendous benefits, we must also address challenges and unintended consequences to ensure equal access and responsible use of digital technology in education. Bridging the digital divide requires concerted efforts to provide technology and internet access to all learners. Additionally, promoting digital literacy skills among educators and students is vital to enable them to navigate the digital landscape confidently and responsibly.

This talk will explore how the digital revolution is reshaping education, making it more inclusive, engaging, and dynamic. Tools, strategies and best-practice approaches will be considered to ensure we can create a brighter future for education and training within the Biomedical Science sector, whilst also suggesting ways to address the most common challenges and pitfalls, so that students and trainees can unleash their full potential.

CONGRESS 2023 - Spatial Transcriptomics: A novel tool to elucidate cell populations in non-melanoma skin cancers

Non-melanoma skin cancers (NMSC) are on the rise, with around 156,000 cases diagnosed annually in the United Kingdom. Basal cell carcinoma (BCC) is the most predominant form that is encountered, and cutaneous squamous cell carcinoma (cSCC) accounts for 20% of all non-melanoma skin cancers. Although the vast majority of non-melanoma skin cancers have a good prognosis and can be cured by surgical intervention, they can cause the destruction of local tissue architecture due to tumour growth. Moreover, a small subset of tumours have poorer outcomes with metastases and mortality.

The underlying biological mechanisms governing a higher risk of recurrence, metastasis, and death remain poorly understood due to a lack of accurate risk stratification. Risk prediction is important in the management of NMSC, as it informs which patients require imaging, how frequently imaging should be performed and how frequently patients should be reviewed. It also informs which patients will benefit from wider surgical resection, adjuvant radiotherapy or sentinel lymph node biopsy. In the future, there is a role for the use of adjuvant immunotherapy for patients with particularly high-risk tumours. This presentation aims to highlight the use of single-cell and spatial transcriptomics analysis approaches in comprehensively mapping the localisation of the different cellular subpopulations in non-melanoma skin cancers. The ultimate aim is to develop better diagnostic tools and markers to predict patient risk status, which will lead to better clinical outcomes.